Get started
Oscar Health, Inc.Oscar Health, Inc.Oscar Health, Inc.

Oscar Health, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

OSCR trade ideas

Oscar (OSCR) – Tech-Enabled Healthcare with Margin Momentum Company Snapshot: Oscar NYSE:OSCR Health is a technology-focused health insurer leveraging data and digital platforms to deliver affordable, personalized care. Its platform-centric model improves member experience, cost control, and care outcomes—setting it apart in a highly regulated sector. Key Catalysts: Steady Execution Under Proven Leadership 🧠 CEO Mark Bertolini (ex-Aetna) brings credibility and strategic clarity, reinforcing investor trust in Oscar’s long-term viability. Focus remains on operational discipline, risk management, and scalable infrastructure. 2025 Guidance Reaffirmed 📊 Following a solid quarter, Oscar reaffirmed full-year 2025 guidance, projecting margin expansion and sustained growth despite sector headwinds. Medical loss ratio (MLR) held steady at 75.4%, absorbing a $31M prior-period hit—showing resilience in cost containment. Robust Financial Flexibility 💰 With $1B+ in free cash flow, Oscar is well-positioned for: Organic growth in new markets Potential share buybacks or dividends Continued investment in digital infrastructure Investment Outlook: Bullish Entry Zone: Above $17.00–$17.50 Upside Target: $32.00–$33.00, supported by margin stability, capital strength, and smart execution. 🩺 Oscar is transforming health insurance from reactive to predictive—backed by tech, discipline, and capital strength. #OscarHealth #OSCR #HealthTech #InsurTech #DigitalHealth #MarkBertolini #MedicalLossRatio #FreeCashFlow #TechEnabledCare #HealthcareStocks #Bullish #ValueDelivery #HealthInnovation
NYSE:OSCRLong
by Richtv_official
OSCR played out, where to DCA?OSCR played out nicely with a huge pop off price action. I was able to sell my leaps, and have already realized a few weeks of unassigned covered-calls. During the bounces near the bottom zone I was adding every few days. Where do I plan on averaging up? Around 17.5$ if we get there. I will also sell CSP within this zone. Oscar like hims challenges the big legacy model of healthcare. The 24$ zone will continue to be an area of huge resistance. This is the highest volume the stock has ever had, a good sign.
NYSE:OSCRLong
by Apollo_21mil
here is the #chart for $OSCR Neutral with upside potential. Oscar Health ( NYSE:OSCR ) is at $20.41, down 0.34% daily but up 36.43% monthly, as shown in the finance card above. X posts highlight strong bullish sentiment, with a weekly wedge breakout and high volume fueling optimism for a move toward $25-$30. Fundamentals are solid, with 42% Q1 2025 revenue growth, $1.2B net cash, and 660% EPS growth projected for 2025. However, volatility (13% weekly) and a downgrade to Market Perform by Raymond James (price target cut to $18) signal caution. Support is at $19.50-$20; resistance is at $21.36-$23.79. A breakout above $21.36 could target $25, but earnings concerns and a high valuation (255% premium per Morningstar) cap near-term upside
NYSE:OSCR
by akyolburak701
OSCR Weekly Trading Plan – June 20, 2025🟢 OSCR Weekly Trading Plan – June 20, 2025 🎯 Instrument: OSCR (Oscar Health) 📈 Direction: Long (Shares) 📊 Confidence Level: 72% ⏰ Time Horizon: 3–4 Weeks ⚠️ Market Condition: Volatile, meme-stock behavior, overbought risk 🧠 Model Consensus Snapshot Model Direction Key Takeaways DS 🔻 Short RSI 76, euphoric price surge, meme risk; targets $17.50 LM 🔼 Long Still bullish above $20.50, target $22.55, careful sizing GK ⏸️ Watch Wait for dip to $19.25–$20.50, bullish bias if pullback GM ⏸️ Watch Avoid for now, entry only if retesting $19.50 CD 🔼 Long Trade at open with $26.50 target; wide stop at $18.50 🧾 Summary & Final Decision 📌 Overall Market View: Strong short-term uptrend is still active, but all models agree we are at overbought RSI levels. The price has surged ~50% in 5 days — historically unsustainable for "meme-like" setups. 📉 Bearish Risks: RSI > 75 Elevated VIX = increased whipsaw risk Meme-stock volatility Potential for profit-taking or rug-pull behavior 📈 Bullish Catalysts: Technical breakout confirmed above key EMAs High volume + news momentum Heavy interest from social media channels ✅ Final Trade Recommendation Parameter Value 📉 Direction LONG (Shares) 💵 Entry Price $21.00 (limit open) 🛑 Stop Loss $18.50 🎯 Target Profit $26.50 🔢 Size 12 shares (based on $10K acct, ~2.5% risk) 📅 Holding Period 3–4 weeks 📈 Confidence 72% 📌 NOTE: Reduce size and tighten stops if market volatility continues rising next week. 📊 TRADE_DETAILS (JSON Format) json Copy Edit { "instrument": "OSCR", "direction": "long", "entry_price": 21.00, "stop_loss": 18.50, "take_profit": 26.50, "size": 12, "confidence": 0.72, "entry_timing": "open" } ⚠️ Risk Considerations Overbought RSI: Expect choppiness and high risk of short-term reversal. Meme stock volatility: News, Reddit chatter, or influencer tweets may spike/dump price irrationally. VIX > 20: Use limit orders to avoid bad fills on open. 💡 This is a high-risk, high-reward momentum play. Stick to your stop-loss and use small sizing.
NYSE:OSCRLong
by quantsignals
Bullish Thesis: Why Oscar Health OSCR Could Rally Strong in 2025Oscar Health, OSCR, a technology-driven health insurance company, is positioned for a significant stock price appreciation in 2025. Despite some mixed short-term sentiment, the long-term outlook and recent analyst forecasts suggest a potential rally that could more than double the current share price. Here’s why OSCR could be a compelling bullish opportunity this year: 1. Strong Analyst Price Targets Indicate Upside of Over 125% According to recent forecasts, OSCR is expected to reach an average price of $31.40 in 2025, with some analysts projecting highs as much as $41.31—a potential upside exceeding 125% from the current price near $13.95. Monthly forecasts show a steady upward trajectory, with July 2025 targets around $37.24 and December 2025 targets near $34.67, highlighting sustained bullish momentum throughout the year. The average 12-month price target is around $34.40, representing a 146% upside, signaling strong confidence in OSCR’s growth prospects. 2. Innovative Business Model and Growth Potential Oscar Health leverages technology and data analytics to offer user-friendly, transparent health insurance plans, differentiating itself in a traditionally complex industry. Its focus on member engagement, telemedicine, and cost-effective care management positions it well to capture market share as healthcare consumers increasingly demand digital-first solutions. The company’s expanding footprint in both individual and Medicare Advantage markets provides multiple growth avenues. 3. Long-Term Vision and Market Opportunity Beyond 2025, forecasts remain highly bullish, with OSCR projected to reach $53.77 by 2027 and nearly $100 by 2030, reflecting strong secular growth potential in the health insurance and digital health sectors. Analysts see Oscar as a disruptive force with the potential to reshape healthcare delivery, driving substantial long-term shareholder value. 4. Improving Financial Metrics and Operational Execution Oscar has been improving its loss ratios and operating efficiencies, which are critical for sustainable profitability. The company’s investments in technology infrastructure and data-driven care management are expected to translate into better margins and revenue growth over time. 5. Market Sentiment and Analyst Ratings While some platforms show mixed short-term sentiment, the dominant analyst consensus is a "Buy" or "Moderate Buy," supported by strong price targets and growth forecasts. The stock’s current undervaluation relative to its growth potential creates a favorable risk-reward profile for investors.
NYSE:OSCRLong
by TopgOptions
What's going on with $OSCR? Let's break it down!🚨 What's going on with NYSE:OSCR ? Let's break it down! 👇 📌 Long-term investors: Every dip = buy/add opportunity 📌 Traders: Short term, we may fill the $13.31 GAP 🔹 Massive volume shelf & consolidation between $11-$17 for nearly 2 years—the bigger the base, the bigger the breakout! 🔹 Rising trendline since April lows—if this breaks, expect a move to $13.31 GAP, possibly $11-$12. Strong support here unless bad news or a market correction hits. 🔹 Break above $18.27 (earnings pop) = 🚀 $20+ short term 🔹 200DMA rejection after retest from below = bearish short term 🔹 WR% is making a lower low instead of swinging higher—watching this closely. 🧐 Overall: We’re in a consolidation phase—when it moves, expect it to be quick & explosive 🔥 Best strategy: DCA & wait for the inevitable surge to $20+ (barring major setbacks). Stay patient. Stay focused. NYSE:OSCR ’s move is coming! 💪
NYSE:OSCRLong
by RonnieV29
OSCR ready to bounce and extend off of long term VWAPBlue line = 200 EMA Light blue line = 50 EMA Golden line = VWAP anchored at OSCR's IPO Pink line = VWAP anchored off of bullish daily candle at the all time low reversal 12/29/22 Green line = VWAP anchored at the 3/28/23 gap up through the pink VWAP + massive volume spike 3/28/23 I'm seeing a pattern that when the price breaks below both the 50/200 EMA and the green and pink VWAPs it's followed by a strong reversal to the upside. In addition, if you apply Elliot Wave Theory, the stock has appeared to have completed an ABC correction, begun a new impulse wave, and waiting to find support to validate that wave 2 is complete before it begins a longer wave 3.
NYSE:OSCRLong
by FunkValley
OSCR 1W — When the Chart Speaks Before the FundamentalsThe Oscar Health chart is currently forming a textbook cup and handle — a long-term reversal structure that has completed its base and is now breaking out of the consolidation zone. The bullish structure is confirmed through price action, volume, and positioning relative to key moving averages. The price has broken through the upper boundary of the handle, shaped as a descending wedge. The breakout is accompanied by increased volume — a clear sign of capital rotation out of accumulation. All major moving averages (EMA, MA50, MA200, WMA) are trending upward, and the price is holding above them all, confirming the bullish momentum. According to Fibonacci extension levels, drawn from the historical low of $1.50 to the peak near $23.26, the first wave target stands at $36.71 (1.618 level), with an extended target at $45.02 (2.0 level). Structurally, the setup suggests a medium-term scenario pointing from current levels toward the $36–45 range, with the potential to repeat the kind of explosive move seen during the 2023 phase, when the price increased more than sixfold. On the fundamental side, Oscar Health is actively recovering: in 2024, revenue grew by more than 50%, net losses were cut nearly in half, and the client base continued to expand. The company is strengthening its share in the digital insurance market and gaining support from institutional investors, including Morgan Stanley and Capital Group. The latest quarterly report was positively received. The breakout is technically clean and fundamentally supported. The immediate pullback zones sit at $14.95 and $13.40. Below that, moving averages may act as control zones for reaction.
NYSE:OSCRLong
by TotoshkaTrades
OSCR to bounce Oscar had outstanding earnings and presented another opportunity for an entry. This company provides a new way to think about health insurance. Employers will save money by providing direct-to-employee insurance plans. This allows employees to avoid being lumped into an average basket of healthy, middle-of-the-road, and sicker colleagues. this phenomenon causes overpaying for many employees. TA-wise: We see a break of the resistance, and a retest to come. On the break, I sold my 35$ LEAPS I bought a while back and locked in a 50% win. I still have 25$ LEAPS but am considering adding commons or some ITM LEAPS. My near-term target is around 18$ or about a 33% upside.
NYSE:OSCRLong
by Apollo_21mil